Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xspray Pharma Major Shareholding Notification 2022

Apr 11, 2022

3129_iss_2022-04-11_74d81bad-be18-4f0d-8734-77d01d066a62.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer XSpray Pharma AB (publ)

Holder

Flerie Invest AB

Instrument

Instrument Aktie SE0009973563
Before the transaction
Shares 1,612,904
Voting rights 1,612,904
Transaction
Date 11/04/2022
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 2,072,096
Shares 2,072,096
Directly held voting rights 2,072,096
Indirectly held voting rights 0

Percentage

Directly held shares 10.01961 %
Directly held voting rights 10.01961 %
Indirectly held voting rights 0 %

Resulting distribution of total

holdings
Percentage of voting
rights:
Number of underlying
shares:
Shares 10.01961 % 2,072,096
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 10.01961 % 2,072,096
Group
total
holdings
Voting rights
2,072,096
Percentage of voting rights 10.01961
Published
11/04/2022 18:18
Contact
Name
Thomas Eldered
Phone
0708-676210
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25